Citius Pharmaceuticals Inc (CTXR)
0.71
-0.01
(-0.91%)
USD |
NASDAQ |
Apr 25, 13:24
Citius Pharmaceuticals Cash from Operations (TTM): -30.37M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -30.37M |
| September 30, 2023 | -29.06M |
| June 30, 2023 | -28.59M |
| March 31, 2023 | -26.72M |
| December 31, 2022 | -28.53M |
| September 30, 2022 | -28.36M |
| June 30, 2022 | -27.62M |
| March 31, 2022 | -24.73M |
| December 31, 2021 | -19.34M |
| September 30, 2021 | -24.25M |
| June 30, 2021 | -22.02M |
| March 31, 2021 | -21.18M |
| December 31, 2020 | -21.38M |
| September 30, 2020 | -16.93M |
| June 30, 2020 | -16.48M |
| March 31, 2020 | -16.01M |
| December 31, 2019 | -15.39M |
| September 30, 2019 | -12.44M |
| June 30, 2019 | -12.04M |
| March 31, 2019 | -10.76M |
| December 31, 2018 | -11.04M |
| September 30, 2018 | -11.32M |
| June 30, 2018 | -12.24M |
| March 31, 2018 | -12.40M |
| December 31, 2017 | -9.098M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.971M |
| June 30, 2017 | -6.309M |
| March 31, 2017 | -6.468M |
| December 31, 2016 | -6.518M |
| September 30, 2016 | -5.900M |
| June 30, 2016 | -4.839M |
| March 31, 2016 | -2.905M |
| December 31, 2015 | -2.348M |
| September 30, 2015 | -2.385M |
| June 30, 2015 | -1.729M |
| March 31, 2015 | -1.133M |
| December 31, 2014 | -1.338M |
| June 30, 2014 | -0.6102M |
| March 31, 2014 | -0.565M |
| December 31, 2013 | -0.5423M |
| September 30, 2013 | -0.0206M |
| June 30, 2013 | -0.0187M |
| March 31, 2013 | -0.0214M |
| December 31, 2012 | -0.0184M |
| September 30, 2012 | -0.0203M |
| June 30, 2012 | -0.0198M |
| March 31, 2012 | -0.019M |
| December 31, 2011 | -0.0199M |
| September 30, 2011 | -0.0208M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-30.37M
Minimum
Dec 2023
-12.04M
Maximum
Jun 2019
-22.18M
Average
-22.02M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
| QuidelOrtho Corp | 280.20M |
| TransCode Therapeutics Inc | -2.315M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |